KalVista Pharmaceuticals, Inc. short interest in 2021
In 2021, KalVista Pharmaceuticals, Inc.'s disclosed short interest ran from 2.23% of shares outstanding on 15 Jan 2021 to 3.87% on 31 Dec 2021, a change of +1.64 percentage points. The year's high was 8.21% on 30 Jun 2021 and its low 2.23% on 15 Jan 2021, averaging 5.18% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.44 days on 13 Aug 2021. Full history: KalVista Pharmaceuticals, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 2.23% (15 Jan 2021)
- End of year
- 3.87% (31 Dec 2021)
- Change
- +1.64 pp
- High
- 8.21% (30 Jun 2021)
- Low
- 2.23% (15 Jan 2021)
- Average
- 5.18%
- Highest days to cover
- 18.44 (13 Aug 2021)
- SEC filings marked
- 9
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 2.23% | 3.25 | |
| 29 Jan 2021 | 2.86% | 4.71 | |
| 12 Feb 2021 | 3.57% | 1.00 | results (8-K) |
| 26 Feb 2021 | 4.36% | 1.51 | |
| 15 Mar 2021 | 3.20% | 2.37 | 10-Q filed, results (8-K) |
| 31 Mar 2021 | 4.86% | 2.70 | |
| 15 Apr 2021 | 5.35% | 4.13 | |
| 30 Apr 2021 | 5.52% | 3.14 | |
| 14 May 2021 | 5.90% | 6.78 | |
| 28 May 2021 | 5.67% | 6.77 | |
| 15 Jun 2021 | 5.89% | 10.81 | |
| 30 Jun 2021 | 8.21% | 4.46 | |
| 15 Jul 2021 | 8.02% | 9.16 | 10-K filed, results (8-K) |
| 30 Jul 2021 | 7.88% | 10.32 | |
| 13 Aug 2021 | 7.58% | 18.44 | |
| 31 Aug 2021 | 7.21% | 12.91 | |
| 15 Sep 2021 | 5.69% | 10.14 | 10-Q filed, results (8-K) |
| 30 Sep 2021 | 4.85% | 3.84 | |
| 15 Oct 2021 | 5.04% | 5.53 | |
| 29 Oct 2021 | 4.44% | 5.42 | |
| 15 Nov 2021 | 4.23% | 9.19 | |
| 30 Nov 2021 | 3.95% | 4.87 | |
| 15 Dec 2021 | 3.86% | 3.32 | 10-Q filed, results (8-K) |
| 31 Dec 2021 | 3.87% | 4.22 |
See also: KalVista Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.